Epidemiological study of hypothyroidism as cardiovascular risk in population;Epidemiologická studie hypotyreózy jako kardiovaskulá rního rizika v populaci

Casopis Lekaru Ceskych

Volumn 144, Issue 7, 2005, Pages 459-465

  Mayer Jr , Otto ^a,c   Simon J ^a   Hrbkova J ^a   Pikner, R ^b   Topolcan O ^b   Dvořáková, Marcela ^d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Endokrinologický Ústav ^*  (Czech Republic)

^d INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Cardiovascular risk; Dysfunction; Epidemiology; Population; Thyroid

Indexed keywords

LIOTRIX; THYROTROPIN;

ARTICLE; CARDIOVASCULAR RISK; CZECH REPUBLIC; FEMALE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; VASCULAR DISEASE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CZECH REPUBLIC; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 22644436787     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Michalopoulou, G., Alevizaki, M., Piperingos, G. et al.: High serum cholesterol levels in persons with 'high normal' TSH levels: should one extend the definition of subclinical hypothyroidism. Eur. J. Endocrinol., 1998, 138, s. 141-145.
2. Bindels, A. J., Westendorp, R. G., Frolich, M. et al.: The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding? Clin. Endocrinol., 1999, 50, s. 217-220.
3. Christ-Crain, M., Meier, C., Guglielmetti, M. et al.: Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidsm? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis, 2003, 166, s. 379-386.
4. Morris, M. S., Bostom, A. G., Jacques, P. F. et al.: Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis, 2001, 155, s. 195-200.
5. Diekman, T., Demacker, P. N., Kastelein, J. J. et al.: Increased oxidizability of low-density lipoproteins in hypothyroidism. J. Clin. Endocrinol. Metab., 1998, 83, s. 1752-1755.
6. Kung, A. W., Pang, R. W., Janus, E. D.: Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin. Endocrinol., 1995, 43, 445-449.
7. Lekakis, J., Papamichael, C., Alevizaki, M. et al.: Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid, 1997, 7, s. 411-414.
8. Forfar, J. C., Wathen, C. G., Todd, W. T. et al.: Left ventricular performance in subclinical hypothyroidism. QJ Med., 1985, 57, s. 857-865.
9. Foldes, J., Istvanfy, M., Halmagyi, M. et al.: Hypothyroidism and the heart. Examination of left ventricular function in subclinical hypothyroidism. Acta Med. Hung., 1987, 44, s. 337-347.
10. Arem, R., Rokey, R., Kiefe, C. et al.: Cardiac systolic and diastolic function at rest and exercise in subclinical hypothyroidism: Effect of thyroid hormone therapy. Thyroid, 1996, 6, s. 397-402.
11. Biondi, B., Fazio, S., Carella, C. et al.: Cardiac effects of long term thyrotropin-suppresive therapy with with levothyroxine. J. Clin. Endocrinol. Metab., 1993, 77, s. 334-338.
12. Baloch, Z., Carayon, P., Conte-Devolx, B. et al.: Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 2003, 13, s. 3-126.
13. De Backer, G., Ambrosioni, E., Borch-Johnsen, K. et al.: European Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J., 2003, 24, s. 1601-1610.
14. Rivolta, G., Cerutti, R., Colombo, R. et al.: Prevalence of suclinical hypothyroidism in a population living in the Milan metropolitan area. J. Endocrinol. Invest., 1999, 22, s. 693-697.
15. Parle, J. V., Franklyn, J. A., Cross, K. W.: Prevalence and follow-up of abnormal thyrotropin (TSH) concentration in the elderly in the United Kingdom. Clin. Endocrinol., 1991, 34, s. 77-83.
16. Pirich, C., Müllner, M., Sinziger, H.: Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J. Clin. Epidemiol., 2000, 53, s. 623-629.
17. Hollowell, J., Staehling, N. W., Flanders, W. D. et al.: Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Healh and Nutrition Examination Survey (NHANES III.) J. Clin. Endocrinol. Metab., 2002, 87, s. 489-499.
18. Canaris, G. J., Manowitz, N. R., Mayor, G. et al.: The Colorado thyroid disease prevalence study. Arch. Intern. Med., 2000, 160, s. 526-534.
19. Cífková, R., Zamrazil, V., Škodová, Z. et al.: Tyreopatie a dyslipidemie u reprezentativního vzorku české populace. DMEV, 2004, 7 (Suppl. 3), s. 13.
20. Hrbková, J., Mayer, O. Jr., Šimon, J. et al.: Epidemiologická Studie subklinických forem dysfunkce štítné žlázy v plzeňské populaci. DMEV, 2002, 5 (Suppl. 3), s. 16.
21. Hak, A. E., Pols, H. A. P., Visser, T. J. et al.: Subclinical hypothyroidsm is an independent risk factor for atherosclerosis and myocardial infarction in elderly women. The Rotterdam study. Ann. Intern. Med., 2000, 132, s. 270-278.
22. Parle, J. V., Maisonneuve, P., Sheppard, M. C.: Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet, 2001, 358, s. 861-865.
23. Tunbridge, W. M. G., Evered, D. C., Hall, R. et al.: The spectrum of thyroid disease in a community: The Wickham survey. Clin. Endocrinol., 1977, 7, s. 481-493.